Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 1
2009 2
2010 7
2011 7
2012 10
2013 7
2014 5
2015 6
2016 2
2017 6
2020 4
2021 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
Xiong J, Cheng S, Gao X, Yu SH, Dai YT, Huang XY, Zhong HJ, Wang CF, Yi HM, Zhang H, Cao WG, Li R, Tang W, Zhao Y, Xu PP, Wang L, Zhao WL. Xiong J, et al. Among authors: wang cf. Signal Transduct Target Ther. 2024 Mar 6;9(1):62. doi: 10.1038/s41392-024-01782-8. Signal Transduct Target Ther. 2024. PMID: 38448403 Free PMC article. Clinical Trial.
GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis.
Xiong J, Dai YT, Wang WF, Zhang H, Wang CF, Yin T, Cheng S, Zhong HJ, Yu SH, Jiang L, Wang SY, Fang H, Zhang RH, Zhu Y, Yi HM, Jiang XF, Chen JY, Wang L, Xu PP, Chen SJ, Zhao WL. Xiong J, et al. Among authors: wang cf. Sci Bull (Beijing). 2023 Nov 15;68(21):2607-2619. doi: 10.1016/j.scib.2023.09.029. Epub 2023 Sep 22. Sci Bull (Beijing). 2023. PMID: 37798178 Free article.
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study.
Zhang MC, Fang Y, Xu PP, Dong L, Shen R, Huang YH, Fu D, Yan ZX, Cheng S, Jiang XF, Song Q, He Y, Zhao Y, Lu M, Ye J, Liu F, Cheng L, Wang CF, Wang L, Zhao WL. Zhang MC, et al. Among authors: wang cf. Clin Transl Med. 2021 Dec;11(12):e584. doi: 10.1002/ctm2.584. Clin Transl Med. 2021. PMID: 34923760 Free PMC article. No abstract available.
Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trial.
Zhao CX, Wen JJ, Fu D, Xu PP, Cheng S, Wang L, Wang CF, Fei XC, Wang X, Zhou JF, Su LP, Chen ZW, Chen JP, Fang MY, Liu T, Song YP, Yu K, Li Y, Gu J, Hou M, Zhao WL, da Hu J. Zhao CX, et al. Among authors: wang cf. Clin Transl Med. 2021 Sep;11(9):e539. doi: 10.1002/ctm2.539. Clin Transl Med. 2021. PMID: 34586746 Free PMC article. Clinical Trial. No abstract available.
A cohort autopsy study defines COVID-19 systemic pathogenesis.
Yao XH, Luo T, Shi Y, He ZC, Tang R, Zhang PP, Cai J, Zhou XD, Jiang DP, Fei XC, Huang XQ, Zhao L, Zhang H, Wu HB, Ren Y, Liu ZH, Zhang HR, Chen C, Fu WJ, Li H, Xia XY, Chen R, Wang Y, Liu XD, Yin CL, Yan ZX, Wang J, Jing R, Li TS, Li WQ, Wang CF, Ding YQ, Mao Q, Zhang DY, Zhang SY, Ping YF, Bian XW. Yao XH, et al. Among authors: wang cf. Cell Res. 2021 Aug;31(8):836-846. doi: 10.1038/s41422-021-00523-8. Epub 2021 Jun 16. Cell Res. 2021. PMID: 34135479 Free PMC article.
COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study.
Zhang YJ, Yang WJ, Liu D, Cao YQ, Zheng YY, Han YC, Jin RS, Han Y, Wang XY, Pan AS, Dai JY, Sun QF, Zhao FQ, Yang QY, Zhang JH, Liu SJ, Da Q, Guo W, Li CQ, Zhang WT, Wu H, Chen XS, Ji AQ, Xiang J, Chen K, Feng XJ, Zhang XF, Cao QQ, Qin L, Li J, Zhou M, Lu Y, Wang CF, Yan FH, Li HC, Qu JM. Zhang YJ, et al. Among authors: wang cf. Transl Lung Cancer Res. 2020 Aug;9(4):1516-1527. doi: 10.21037/tlcr-20-892. Transl Lung Cancer Res. 2020. PMID: 32953523 Free PMC article.
63 results